PURE Bioscience, Inc. (OTCMKTS:PURE) Short Interest Update

PURE Bioscience, Inc. (OTCMKTS:PURE) was the target of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 46,600 shares, a growth of 50.8% from the October 15th total of 30,900 shares. Based on an average daily volume of 50,300 shares, the short-interest ratio is currently 0.9 days.

PURE Bioscience Stock Performance

Shares of OTCMKTS PURE remained flat at $0.16 during midday trading on Friday. 21,473 shares of the stock were exchanged, compared to its average volume of 28,810. The firm has a fifty day simple moving average of $0.09 and a 200 day simple moving average of $0.08. PURE Bioscience has a 1 year low of $0.06 and a 1 year high of $0.17. The company has a market cap of $17.62 million, a price-to-earnings ratio of -3.94 and a beta of 0.05.

PURE Bioscience (OTCMKTS:PURE) last announced its quarterly earnings data on Tuesday, October 29th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $0.47 million during the quarter.

About PURE Bioscience

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.